{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:00Z","timestamp":1707524520496},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,7]]},"DOI":"10.7759\/cureus.23905","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T09:47:53Z","timestamp":1649324873000},"source":"Crossref","is-referenced-by-count":0,"title":["The Treatment of Psychotic Depression in a 64-Year-Old Patient With Carcinoid Syndrome"],"prefix":"10.7759","author":[{"given":"Jason","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Carcinoid syndrome","author":"Pandit S","year":"2021","unstructured":"Pandit S, Annamaraju P, Bhusal K. Carcinoid syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island, Florida; 2021."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.662","article-title":"Complications from carcinoid syndrome: review of the current evidence","volume":"10","author":"Mota JM","year":"2016","unstructured":"Mota JM, Sousa LG, Riechelmann RP. Complications from carcinoid syndrome: review of the current evidence. Ecancermedicalscience. 2016, 10:662. 10.3332\/ecancer.2016.662","journal-title":"Ecancermedicalscience"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley DS","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, et al.. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017, 89:218-35. 10.1016\/j.jclinepi.2017.04.026","journal-title":"J Clin Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.41.479.566","article-title":"Carcinoid syndrome associated with psychosis","volume":"41","author":"Hanna SM","year":"1965","unstructured":"Hanna SM. Carcinoid syndrome associated with psychosis. Postgrad Med J. 1965, 41:566-7. 10.1136\/pgmj.41.479.566","journal-title":"Postgrad Med J"},{"key":"ref5","article-title":"Neuroendocrine carcinoid cancer associated with psychosis","volume":"5","author":"Kohen I","year":"2008","unstructured":"Kohen I, Arbouet S. Neuroendocrine carcinoid cancer associated with psychosis. Psychiatry (Edgmont). 2008, 5:29-30.","journal-title":"Psychiatry (Edgmont)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1708\/1319.14626","article-title":"Comorbility between anxiety and depression in patients with carcinoid tumors (Article in Italian)","volume":"48","author":"Moretti P","year":"2013","unstructured":"Moretti P, Dennis JL, Stella A, et al.. Comorbility between anxiety and depression in patients with carcinoid tumors (Article in Italian). Riv Psichiatr. 2013, 48:301-6. 10.1708\/1319.14626","journal-title":"Riv Psichiatr"},{"key":"ref7","unstructured":"National Institute for Health and Care Excellence (NICE). Depression in adults: recognition and management. (2009). Accessed: September 20, 2021: https:\/\/www.nice.org.uk\/guidance\/cg90."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2019.1546691","article-title":"Vortioxetine: a novel antidepressant for the treatment of major depressive disorder","volume":"14","author":"Gonda X","year":"2019","unstructured":"Gonda X, Sharma SR, Tarazi FI. Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. Expert Opin Drug Discov. 2019, 14:81-9. 10.1080\/17460441.2019.1546691","journal-title":"Expert Opin Drug Discov"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2021.152244","article-title":"Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review","volume":"109","author":"La Salvia A","year":"2021","unstructured":"La Salvia A, Portigliatti Pomeri A, Persano I, et al.. Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review. Compr Psychiatry. 2021, 109:152244. 10.1016\/j.comppsych.2021.152244","journal-title":"Compr Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0567-5","article-title":"Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge","volume":"45","author":"Erritzoe D","year":"2020","unstructured":"Erritzoe D, Ashok AH, Searle GE, et al.. Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge. Neuropsychopharmacology. 2020, 45:804-10. 10.1038\/s41386-019-0567-5","journal-title":"Neuropsychopharmacology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68249-the-treatment-of-psychotic-depression-in-a-64-year-old-patient-with-carcinoid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:42Z","timestamp":1707507882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68249-the-treatment-of-psychotic-depression-in-a-64-year-old-patient-with-carcinoid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.23905","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,7]]}}}